v3.26.1
Segment Information (Tables)
6 Months Ended 12 Months Ended
Jun. 30, 2026
Dec. 31, 2025
Segment Information    
Schedule of significant expense categories

Three Months Ended

Six Months Ended

June 30, 

June 30, 

(in thousands)

2026

  ​ ​ ​

2025

  ​ ​ ​

2026

  ​ ​ ​

2025

Research and development expenses

Employee costs

$

1,536

$

2,341

$

3,575

$

5,271

Clinical product candidates

4,250

2,569

7,290

5,604

Nonclinical product candidates

746

981

1,604

1,646

Depreciation and amortization

265

618

541

1,254

Other R&D(1)

628

17,582

1,249

18,212

Total R&D

$

7,425

$

24,091

$

14,259

$

31,987

General and administrative expenses

Employee costs

$

877

$

1,374

$

2,400

$

3,451

Professional services

1,160

1,266

2,273

2,346

Insurance

233

243

455

505

Other G&A(2)

322

318

735

625

Total G&A

$

2,592

$

3,201

$

5,863

$

6,927

(1)Other R&D consists of facilities related expenses and office expenses and includes $17 million related to the License Agreement with Zaiming for both the three and six months ended June 30, 2025 (Note 3).
(2)Other G&A consists of facilities related expenses, depreciation, office expenses and taxes and fees.

The tables below summarize the significant expense categories regularly reviewed by the CODM for the years ended December 31, 2025 and 2024:

Year Ended

December 31, 

(in thousands)

2025

  ​ ​ ​

2024

Research and development expenses

Employee costs

$

8,974

$

13,252

Clinical product candidates

27,669

13,562

Nonclinical product candidates

3,758

9,182

Depreciation and amortization

2,133

2,792

Other R&D(1)

2,389

2,700

Total R&D

$

44,923

$

41,488

General and administrative expenses

Employee costs

$

5,887

$

8,400

Professional services

4,614

4,449

Insurance

947

1,281

Other G&A(2)

1,245

1,588

Total G&A

$

12,693

$

15,718

(1)Other R&D consists of facilities related expenses and office expenses.

(2)Other G&A consists of facilities related expenses, depreciation, office expenses and taxes and fees.